Clinical Trials in Washington

Showing 2101-2120 of 8,171 trials

Assessment of Early Pregnancy MAB Completion

NCT06893484

This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.

PregnancyAbortion Early

University of Washington400 participantsStarted Mar 2025

Atlanta, Georgia, United States • Chevy Chase, Maryland, United States • Renton, Washington, United States

COMPLETEDPhase 334 miles

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

NCT05275400

The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes that have already been treated with basal insulin. The study consists of a 3-week screening/lead-in period, a 78-week treatment period and a 5-week safety follow-up period. The study will last up to 86 weeks.

Type 2 Diabetes

Eli Lilly and Company986 participantsStarted Mar 2022

Little Rock, Arkansas, United States • Concord, California, United States • Escondido, California, United States +124 more locations

Assessment of Early Pregnancy MAB Completion

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Find Trials by Condition in Washington

Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Electrical Nerve Block for Amputation Pain

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

DePTH: De-emphasize PTH

Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta

The GBA Multimodal Study in Parkinson's Disease

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)